Jun 11, 2018
Shlomo Yanai Elected to PDL BioPharma's Board of Directors
May 21, 2018
PDL BioPharma Names Dr. Jill Jene Vice President, Business Development
May 15, 2018
PDL BioPharma to Present at Two Upcoming Investor Conferences
May 02, 2018
PDL BioPharma to Announce First Quarter 2018 Financial Results on May 9, 2018
Apr 03, 2018
PDL BioPharma to Present at the H.C. Wainwright Global Life Sciences Conference
Mar 01, 2018
PDL BioPharma to Announce Fourth Quarter / Year-End 2017 Financial Results on March 8, 2018
Feb 20, 2018
PDL BioPharma Terminates Interest in Pursuing Acquisition of Neos
Feb 14, 2018
PDL BioPharma to Present at Two Upcoming Investor Conferences
Nov 08, 2017
PDL BioPharma's Proposal to Acquire Neos Therapeutics Expires Today; PDL Urges Neos to Provide Update on Sale Process
Nov 07, 2017
PDL BioPharma to Present at Two Upcoming Investor Conferences
Oct 30, 2017
PDL BioPharma Issues Statement in Response to Neos Therapeutics Rejection of PDL Acquisition Proposal
Oct 30, 2017
Neos Therapeutics Board of Directors Unanimously Rejects Unsolicited Proposal from PDL BioPharma
Oct 26, 2017
PDL BioPharma Proposes to Acquire Neos Therapeutics for $10.25 per Share in Cash
Oct 25, 2017
PDL BioPharma to Announce Third Quarter 2017 Financial Results on November 2, 2017
Sep 25, 2017
PDL BioPharma Announces New $25 Million Share Repurchase Program
Sep 19, 2017
PDL BioPharma Updates Presentation Time for Cantor Fitzgerald Conference
Sep 11, 2017
PDL BioPharma Appoints Dominique Monnet as President
Sep 06, 2017
PDL BioPharma to Present at Two Upcoming Investor Conferences
Jul 31, 2017
PDL BioPharma to Announce Second Quarter 2017 Financial Results on August 3, 2017